Innoviva announced the creation of Nortiva Bio, a new entity that will build on Langer Lab assets rescued after the collapse of Lyndra Therapeutics. The company aims to develop long‑acting oral medicines and explore drug development alliances.
Daily NewsAug 26, 2026•3 min read
Innoviva Forms Nortiva Bio to Advance Long‑Acting Oral Medicines
Innoviva has launched Nortiva Bio, using rescued Langer Lab assets to develop long‑acting oral medicines and seek drug development alliances.
Compiled by the Pharmacountry team · Source: FiercePharma
Topics:
Ratings
(0)
(0)
(0)
(0)
(0)
Leave your rating